The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

AC1NSF85     1-(2,4-dichlorophenyl)-N- [(2,4...

Synonyms: AC-15734, ZINC03873295, AKOS016010375, FT-0630743, DB00239, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Ro 13-8996


High impact information on Ro 13-8996


Chemical compound and disease context of Ro 13-8996


Biological context of Ro 13-8996

  • Synthesis of DNA was inhibited by subinhibitory concentrations of oxiconazole in parallel to cell multiplication, whereas synthesis of RNA, protein and carbohydrate was decreased to a lesser extent [10].

Associations of Ro 13-8996 with other chemical compounds


Analytical, diagnostic and therapeutic context of Ro 13-8996


  1. Oxiconazole nitrate: pharmacology, efficacy, and safety of a new imidazole antifungal agent. Jegasothy, B.V., Pakes, G.E. Clinical therapeutics. (1991) [Pubmed]
  2. Susceptibility to some antifungal drugs of vaginal lactobacilli isolated from healthy women. Kilic, E., Aslim, B., Taner, Z. Drug metabolism and drug interactions. (2005) [Pubmed]
  3. Oxiconazole in the treatment of vaginal candidiasis: single dose versus 3-day treatment with econazole. Gouveia, D.C., Jones da Silva, C. Pharmatherapeutica. (1984) [Pubmed]
  4. Toxicity of intravitreal oxiconazole. Schulman, J.A., Peyman, G.A., Dietlein, J., Fiscella, R. International ophthalmology. (1989) [Pubmed]
  5. Influence of growth phase on the susceptibility of Candida albicans to butoconazole, oxiconazole, and sulconazole. Beggs, W.H. J. Antimicrob. Chemother. (1985) [Pubmed]
  6. Further in vitro studies with oxiconazole nitrate. Shadomy, S., Wang, H., Shadomy, H.J. Diagn. Microbiol. Infect. Dis. (1988) [Pubmed]
  7. In vitro susceptibility studies with oxiconazole (Ro 13-8996). Gebhart, R.J., Espinel-Ingroff, A., Shadomy, S. Chemotherapy. (1984) [Pubmed]
  8. Terbinafine. A pharmacoeconomic evaluation of its use in superficial fungal infections. Davis, R., Balfour, J.A. PharmacoEconomics. (1995) [Pubmed]
  9. Comparative efficacy of naftifine, oxiconazole, and terbinafine in short-term treatment of tinea pedis. Ablon, G., Rosen, T., Spedale, J. International journal of dermatology. (1996) [Pubmed]
  10. Oxiconazole, a new imidazole derivative. Evaluation of antifungal activity in vitro and in vivo. Polak, A. Arzneimittel-Forschung. (1982) [Pubmed]
  11. Clinical and experimental mycotic corneal ulcer caused by Aspergillus fumigatus and the effect of oral ketoconazole in the treatment. Singh, S.M., Khan, R., Sharma, S., Chatterjee, P.K. Mycopathologia (1989) [Pubmed]
  12. Synthesis and antimycotic activity of some benzyloxyimino compounds. Garuti, L., Giovanninetti, G., Ferranti, A., Chiarini, A., Bertocchi, G., Sabatino, P., Brigidi, P. Die Pharmazie. (1987) [Pubmed]
  13. Sensitive gas-liquid chromatographic method for the determination of oxiconazole in plasma. Timm, U., Zell, M., Herzfeld, L. J. Chromatogr. (1982) [Pubmed]
  14. Clinical and experimental mycotic keratitis caused by Aspergillus terreus and the effect of subconjunctival oxiconazole treatment in the animal model. Singh, S.M., Sharma, S., Chatterjee, P.K. Mycopathologia (1990) [Pubmed]
WikiGenes - Universities